COMMUNIQUÉS West-GlobeNewswire

Zosano Pharma to Host Conference Call on Second Quarter 2018 Financial Results and Provide Operational Update

02/08/2018 - 14:30

FREMONT, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”) a clinical-stage biopharmaceutical company focused on providing rapid systemic administration of [...]

Yield10 Bioscience to Host Webcast of its Second Quarter 2018 Conference Call

02/08/2018 - 14:30

WOBURN, Mass., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), a Company developing new technologies to achieve step-change improvements in crop yield to enhance global food security, announced [...]

Conformis announces election of Carrie Bienkowski to its Board of Directors

02/08/2018 - 14:30

BILLERICA, Mass., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint [...]

ChemoCentryx to Hold Second Quarter 2018 Financial Results Conference Call on Thursday, August 9, 2018

02/08/2018 - 14:30

MOUNTAIN VIEW, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's second quarter 2018 financial results will be released after market close on Thursday, [...]

MPX to Report Fiscal 2018 Earnings Today, Thursday, August 2, 2018; Reschedules Earnings Call

02/08/2018 - 14:30

TORONTO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE: MPX; OTC: MPXEF) today announced the Company will issue its fiscal 2018 full-year results release later today. [...]

Golden Leaf Holdings Receives City Regulatory License For Extraction Facility In Portland

02/08/2018 - 14:30

PORTLAND, Ore., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around recognized [...]

Stealth Mark to Present at the World’s Fair of Money

02/08/2018 - 14:30

Introducing the ACTF Numismatic and Precious Metals Industry Report HOFFMAN ESTATES, IL, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Wellness Center USA, Inc.’s (OTCQB: WCUI) wholly-owned subsidiary, StealthCo, Inc., dba Stealth [...]

Portola Pharmaceuticals to Announce Second Quarter 2018 Financial Results and Host Conference Call on Thursday, August 9, 2018

02/08/2018 - 14:30

SOUTH SAN FRANCISCO, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA) today announced that it will host a webcast and conference call to discuss the Company’s financial results [...]

Terra Tech Corp. Schedules Second Quarter 2018 Earnings Release for Thursday, August 9, 2018

02/08/2018 - 14:30

IRVINE, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX: TRTC) (“Terra Tech” or the “Company”), a vertically integrated, cannabis-focused agriculture company, today announced that it will release its [...]

Viveve to Announce Financial Results for Second Quarter 2018 and Host Conference Call

02/08/2018 - 14:28

ENGLEWOOD, Colo., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, will announce financial results for the second quarter ended June [...]

Voyager Therapeutics to Present at Investor Conferences in August

02/08/2018 - 14:26

CAMBRIDGE, Mass., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe neurological diseases, today announced [...]

Biomerica Receives Notice of Allowance for Irritable Bowel Syndrome (IBS) Test Panel and Methods in Korea

02/08/2018 - 14:19

IRVINE, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq:BMRA) announced today that the Korean Intellectual Property Office (KIPO) has issued a Notice of Allowance for a patent application covering [...]

Genocea Reports Second Quarter 2018 Financial and Operating Results

02/08/2018 - 14:04

Neoantigen vaccine program GEN-009 Phase 1/2a clinical trial underway ATLAS™ platform continues to stand apart from in silico methods of neoantigen identification Conference call today at 9:00 am ET CAMBRIDGE, Mass., [...]

Celldex to Report Second Quarter 2018 Financial Results and Host Corporate Update Call

02/08/2018 - 14:01

HAMPTON, N.J., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) will release second quarter 2018 financial results on Wednesday, August 8, 2018 after the U.S. financial markets close. Celldex [...]

CoolSculpting – New Jersey Plastic Surgeon Discusses Popular Non-Surgical Fat Reduction Treatment

02/08/2018 - 14:01

Dr. Christopher P. Godek of The Personal Enhancement Center says CoolSculpting® continues its rise in popularity as one of the most effective non-surgical options for patients looking to reduce excess fat pockets in a [...]

Oncobiologics Appoints Lawrence A. Kenyon as President and CEO

02/08/2018 - 14:00

CRANBURY, N.J., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that Lawrence A. Kenyon, its Chief Financial Officer (CFO) and Corporate Secretary, has been appointed to the role of [...]

OncoMed Announces Second Quarter 2018 Financial Results and Operational Highlights

02/08/2018 - 14:00

-Company prioritizes its navicixizumab resources in platinum-resistant ovarian cancer; prepares to share data in Q4 of 2018- -Cash runway extended by an additional quarter to YE 2019- REDWOOD CITY, Calif., Aug. 02, 2018 [...]

Celtaxsys Announces Results of Phase 2 Trial Showing Clinically Meaningful Improvement in Pulmonary Exacerbations in Cystic Fibrosis Patients

02/08/2018 - 14:00

-Acebilustat is the first novel anti-inflammatory molecule evidencing the potential to reduce frequency of pulmonary exacerbations and prolong time to first exacerbation in CF patients --Celtaxsys, with continued [...]

Catalyst Biosciences Reports Second Quarter Operating & Financial Results and Provides Corporate Update

02/08/2018 - 14:00

Announced Positive Interim Data from a Phase 2/3 Study of Marzeptacog Alfa (Activated) (FVIIa) in Individuals with Hemophilia A or B with Inhibitors Presented CB 2679d (FIX) Phase 1/2 Data at the World Federation of [...]